Bhanumati Ramineni

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Pfs25 is a leading candidate for a malaria transmission-blocking vaccine whose potential has been demonstrated in a phase 1 trial with recombinant Pfs25 formulated with Montanide ISA51. Because of limited sequence polymorphism, the anti-Pfs25 antibodies induced by this vaccine are likely to have transmission-blocking or -reducing activity against most, if(More)
  • 1